Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Drug-Related Side Effects and Adverse Reactions 10Head and Neck Neoplasms 9Radiation Injuries 7Lung Neoplasms 7Ovarian Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Ovarian Epithelial 5Sarcoma 3Prostatic Neoplasms 3Neurotoxicity Syndromes 3Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia 3Hodgkin Disease 3Breast Neoplasms 3Xerostomia 2Waldenstrom Macroglobulinemia 2Urinary Bladder Neoplasms 2Testicular Neoplasms 2Small Cell Lung Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neutropenia 2Neuroectodermal Tumors, Primitive, Peripheral 2Mucositis 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2

Interventions

Oxaliplatin 146Fluorouracil 137Capecitabine 122Leucovorin 106Irinotecan 85Radiotherapy 67Bevacizumab 64Cetuximab 46Folfox protocol 28Surgical Procedures, Operative 23Radiation 23Drug Therapy 22Panitumumab 19XELOX 18Chemotherapy, Adjuvant 15Neoadjuvant Therapy 14Radiotherapy, Intensity-Modulated 13Chemoradiotherapy 13Magnetic Resonance Spectroscopy 11regorafenib 10Nivolumab 10Floxuridine 10sintilimab 8raltitrexed 8Specimen Handling 8IFL protocol 8Celecoxib 8Biopsy 8trifluridine tipiracil drug combination 7tislelizumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Rectal Neoplasms × Amifostine × Clear all
NCT01586117 2013-08-15

A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity

ChineseAMS

Phase 2 Unknown
40 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡